me 2303 has been researched along with pirarubicin in 1 studies
| Studies (me 2303) | Trials (me 2303) | Recent Studies (post-2010) (me 2303) | Studies (pirarubicin) | Trials (pirarubicin) | Recent Studies (post-2010) (pirarubicin) |
|---|---|---|---|---|---|
| 23 | 1 | 0 | 810 | 133 | 198 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, M; Kanbe, T; Takahashi, Y; Takeuchi, T; Tsuchiya, KS; Uehara, Y | 1 |
1 other study(ies) available for me 2303 and pirarubicin
| Article | Year |
|---|---|
Distinct effects of clinically used anthracycline antibiotics on ras oncogene-expressed cells.
Topics: 3T3 Cells; Actins; Animals; Antibiotics, Antineoplastic; Cell Division; Cell Line, Transformed; Doxorubicin; Enzyme Activation; Gene Expression; Genes, ras; Humans; Mice; Nucleoside-Diphosphate Kinase; Staining and Labeling | 1993 |